Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Prospective Evaluation of Novel Biomarkers to Detect and Predict the Severity of Drug- Associated Acute Pancreatitis in Adults

NCT05279079 is registered in ClinicalTrials.gov with University of Liverpool as lead sponsor.

NCT NCT05279079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05279079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Prospective Evaluation of Novel Biomarkers to Detect and Predict the Severity of Drug- Associated Acute Pancreatitis in Adults
Lead sponsor
University of Liverpool
Phase
Observational
Overall status
Completed
Start date
January 25, 2023
Completion date
January 31, 2025
Enrollment
175 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

acute pancreatitis drug-induced